RNA-based blood genomics as an investigative tool and prospective biomarker for ischemic stroke

Christopher Cox, Frank R Sharp

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Stroke is a leading cause of death and disability, and considerable effort is being expended to investigation of its pathological mechanisms, as well as the identification of clinically relevant biomarkers that could assist in diagnosis. RNA-based analysis of gene expression in blood represents a new field of study addressing both paradigms. A number of recent animal and human studies using microarray technology demonstrate rapidly-induced, measurable changes in gene expression in response to ischemic trauma, and distinct expression 'profiles' specific to the injury subtype. The incorporation of newer technologies for a more detailed transcriptome analysis holds great promise for further improving our knowledge of stroke at the molecular level, and potentially enhancing standards of diagnosis.

Original languageEnglish (US)
Pages (from-to)457-464
Number of pages8
JournalNeurological Research
Volume35
Issue number5
DOIs
StatePublished - Jun 2013

Fingerprint

Genomics
Biomarkers
Stroke
RNA
Technology
Gene Expression
Wounds and Injuries
Gene Expression Profiling
Cause of Death

Keywords

  • Biomarker
  • Blood genomics
  • Gene expression
  • Microarrays
  • RNA
  • Stroke

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

RNA-based blood genomics as an investigative tool and prospective biomarker for ischemic stroke. / Cox, Christopher; Sharp, Frank R.

In: Neurological Research, Vol. 35, No. 5, 06.2013, p. 457-464.

Research output: Contribution to journalArticle

@article{1fd79418d1344bb6bb88014ba56d6eda,
title = "RNA-based blood genomics as an investigative tool and prospective biomarker for ischemic stroke",
abstract = "Stroke is a leading cause of death and disability, and considerable effort is being expended to investigation of its pathological mechanisms, as well as the identification of clinically relevant biomarkers that could assist in diagnosis. RNA-based analysis of gene expression in blood represents a new field of study addressing both paradigms. A number of recent animal and human studies using microarray technology demonstrate rapidly-induced, measurable changes in gene expression in response to ischemic trauma, and distinct expression 'profiles' specific to the injury subtype. The incorporation of newer technologies for a more detailed transcriptome analysis holds great promise for further improving our knowledge of stroke at the molecular level, and potentially enhancing standards of diagnosis.",
keywords = "Biomarker, Blood genomics, Gene expression, Microarrays, RNA, Stroke",
author = "Christopher Cox and Sharp, {Frank R}",
year = "2013",
month = "6",
doi = "10.1179/1743132813Y.0000000212",
language = "English (US)",
volume = "35",
pages = "457--464",
journal = "Neurological Research",
issn = "0161-6412",
publisher = "Maney Publishing",
number = "5",

}

TY - JOUR

T1 - RNA-based blood genomics as an investigative tool and prospective biomarker for ischemic stroke

AU - Cox, Christopher

AU - Sharp, Frank R

PY - 2013/6

Y1 - 2013/6

N2 - Stroke is a leading cause of death and disability, and considerable effort is being expended to investigation of its pathological mechanisms, as well as the identification of clinically relevant biomarkers that could assist in diagnosis. RNA-based analysis of gene expression in blood represents a new field of study addressing both paradigms. A number of recent animal and human studies using microarray technology demonstrate rapidly-induced, measurable changes in gene expression in response to ischemic trauma, and distinct expression 'profiles' specific to the injury subtype. The incorporation of newer technologies for a more detailed transcriptome analysis holds great promise for further improving our knowledge of stroke at the molecular level, and potentially enhancing standards of diagnosis.

AB - Stroke is a leading cause of death and disability, and considerable effort is being expended to investigation of its pathological mechanisms, as well as the identification of clinically relevant biomarkers that could assist in diagnosis. RNA-based analysis of gene expression in blood represents a new field of study addressing both paradigms. A number of recent animal and human studies using microarray technology demonstrate rapidly-induced, measurable changes in gene expression in response to ischemic trauma, and distinct expression 'profiles' specific to the injury subtype. The incorporation of newer technologies for a more detailed transcriptome analysis holds great promise for further improving our knowledge of stroke at the molecular level, and potentially enhancing standards of diagnosis.

KW - Biomarker

KW - Blood genomics

KW - Gene expression

KW - Microarrays

KW - RNA

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=84878283603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878283603&partnerID=8YFLogxK

U2 - 10.1179/1743132813Y.0000000212

DO - 10.1179/1743132813Y.0000000212

M3 - Article

C2 - 23635721

AN - SCOPUS:84878283603

VL - 35

SP - 457

EP - 464

JO - Neurological Research

JF - Neurological Research

SN - 0161-6412

IS - 5

ER -